preloader

PHARMACEUTICAL RESEARCH AND DEVELOPMENT COMMITTEE

Government of India
Ministry of Chemicals & Fertilizers
Department of Chemicals and Petrochemicals
—————————–

No.5(1)/98-PI.I                     

  New Delhi, the 18th March, 1999

Memorandum

It has been decided to constitute a Pharmaceutical Research and Development Committee with a view to recommend measures to strengthen the research and development capability of the pharmaceutical industry in the country and to identify the support required by Indian pharmaceutical companies to undertake domestic R&D. Accordingly, the following Committee is constituted: –

1. Dr. R.A. MASHELKAR Chairman
Director General, C.S.I.R.

2. Additional Secretary, Member
Ministry of Health & F.W.

3. Dr. Anji Reddy Member

4. Dr. Parvinder Singh Membe

5. Dr. Y.K. Hameed Membe

6. Dr. Swati A. Piramal Member

7.  Dr. Rakesh Mohan Member

8. Dr. Amit Mitra Member

9. Dr. Mira Shiva Member

10. Director, Central Drug Research Institute Member Lucknow

11. Chairman, N.P.P.A., Member

12. Director General, Member
I.C.M.R

13. Joint Secretary, (P.I) Member

14. Officer on Special Duty, Convenor/Member
Department of C&PC

 

The terms of reference of the Committee are as follows:-

1. To appraise the current status of R&D in the Indian pharmaceutical sector and to suggest measures to boost it in the context of drug price control regime and changes in laws on Intellectual Property Rights.

2. To suggest new and innovative fiscal and non-fiscal measures for boosting R&D in pharmaceutical sector, and

3. To suggest mechanisms for establishing organic linkages between private sector and government organizations/ laboratories/ universities with a view to synchronizing and synergising national R&D efforts in pharmaceuticals.

4. The Committee will liase closely with the Drug Price Control Review Committee.

5. The Committee will widely consult different interest groups, industry associations, consumers and other organizations/ bodies.

6. The Committee shall submit its report within three months.

(S.K. SOOD)

Joint Secretary to the Government of India

 

Copy to :
Dr. R.A. Mashelkar
Director General,
CSIR & Secretary,
Department of Scientific and Industrial Research,
Anusandhan Bhavan,
Rafi Marg,
New Delhi.
The Additional Secretary,
Ministry of Health & F.W.,
Nirman Bhavan,
New Delhi.

--

Dr. Parvinder Singh
Chairman,
M/s Ranbaxy Ltd.,
19, Nehru Place,
New Delhi.
Dr. Anji Reddy
Chairman,
M/s Reddy Laboratories Ltd.,
7-1-27, Ameerpet,
Hyderabad – 500 016.

--

Dr. Y.K. Hameed
Chairman,
M/s Cipla Ltd.,
289, Bellasis Road,
Mumbai Centre,
Mumbai – 400 008.
Dr.(Mrs.) Swati A. Piramal
Chief Scientific Officer,
100, Centre Point,
Dr. Ambedkar Road,
Parel,
Mumbai – 400 012.

--

Dr. Rakesh Mohan
Director General,
National Council for Applied Economic Research,
Parishila Bhavan,
11, I.P.Estate,
New Delhi.
Dr. Amit Mitra
Secretary General,
F.I.C.C.I.
Federation House,
Tansen Marg,
New Delhi – 110 001.

--

Dr. C.M. Gupta
Director,
Central Drug Research Institute,
Chattar Manjil Palace,
P.O. Box No. 173,
Lucknow.
The Chairman
National Pharmaceutical Pricing Authority,
Jawahar Vyapar Bhavan,
New Delhi.

--

Dr. Mira Shiva
Head of Department,
Department of Public Policy,
Voluntary Health Association of India,
B-40, Qutab Institutional Area,
Behind Qutab Hotel,
New Delhi – 110 016.
Dr. N.K. Ganguli
Director General,
Indian Council of Medical Research,
Ansari Nagar,
Near South Extension part II,
New Delhi – 110 029.

--

The Joint Secretary, (P.I.)
Department of Chemicals and Petrochemicals,
Shastri Bhavan,
New Delhi.
Officer on Special Duty
Department of Chemicals and Petrochemicals,
Shastri Bhavan,
New Delhi.

(S.K. SOOD)

Joint Secretary to the Government of India

Last Page Updated: 31-10-2018